Accessibility Menu
 
Microbot Medical logo

Microbot Medical

(NASDAQ) MBOT

Current Price$2.31
Market Cap$160.51M
Since IPO (2016)-98%
5 Year-71%
1 Year+56%
1 Month-8%

Microbot Medical Financials at a Glance

Market Cap

$160.51M

Revenue (TTM)

$0.00

Net Income (TTM)

$13.14M

EPS (TTM)

$-0.31

P/E Ratio

-7.82

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$2.31

Volume

46,376

Open

$2.42

Previous Close

$2.39

Daily Range

$2.27 - $2.42

52-Week Range

$1.35 - $4.67

MBOT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Microbot Medical

Industry

Healthcare Equipment and Supplies

Employees

43

CEO

Harel Gadot, MBA

Headquarters

Hingham, MA 02043, US

MBOT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-32%

Return on Capital

-19%

Return on Assets

-16%

Earnings Yield

-12.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$160.51M

Shares Outstanding

67.16M

Volume

46.38K

Short Interest

0.00%

Avg. Volume

1.98M

Financials (TTM)

Gross Profit

$47.00K

Operating Income

$14.74M

EBITDA

$14.70M

Operating Cash Flow

$13.05M

Capital Expenditure

$60.00K

Free Cash Flow

$13.11M

Cash & ST Invst.

$78.59M

Total Debt

$865.00K

Microbot Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$10.00K

+61.5%

Gross Margin

0.00%

N/A

Market Cap

$160.51M

N/A

Market Cap/Employee

$8.03M

N/A

Employees

20

N/A

Net Income

$3.46M

-2.1%

EBITDA

$4.13M

-22.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$77.73M

+1350.4%

Accounts Receivable

$241.00K

-19.7%

Inventory

$584.00K

N/A

Long Term Debt

$1.14M

+2675.6%

Short Term Debt

$296.00K

+322.9%

Return on Assets

-16.12%

N/A

Return on Invested Capital

-18.87%

N/A

Free Cash Flow

$3.78M

-122.8%

Operating Cash Flow

$3.76M

-122.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRDLCardiol Therapeutics Inc.
$1.22-2.40%
ORMPOramed Pharmaceuticals Inc.
$3.27-1.06%
RCELAVITA Medical, Inc.
$3.74-2.09%
CNTXContext Therapeutics Inc.
$2.57-0.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.34+0.01%
INTCIntel
$41.41-0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$87.37-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.55-0.00%

Questions About MBOT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.